Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Canon Electron Tubes and Devices Co Ltd | 85 |
| 2 | Proterial Ltd | 20 |
| 3 | Siemens Healthcare GmbH | 13 |
| 4 | Siemens Corp | 11 |
| 5 | Koninklijke Philips NV | 10 |
| 6 | Siemens AG | 8 |
| 7 | Toshiba Corp | 8 |
| 8 | Canon Inc | 7 |
| 9 | Eastman Kodak Co | 7 |
| 10 | Agfa Gevaert NV | 6 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | G01T | 141 | |
| 2 | G21K | 70 | |
| 3 | C09K | Materials for misc. applications | 63 |
| 4 | A61B | 46 | |
| 5 | H10F | 43 |
| 6 | G01N | Investigating / analysing materials | 29 |
| 7 | H04N | 28 | |
| 8 | H01J | 16 | |
| 9 | H01L | Semiconductor devices | 16 |
| 10 | A61N | 14 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionMost-cited patents
Patents ranked by forward citations reveal the foundational inventions the field continues to build on.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| Process for the preparation of gadolinium oxysulfide (Gd2O2S) scintillation ceramics | 2019 | Nuctech Co Ltd | 0 |
| Process for the preparation of gadolinium oxysulfide (Gd2O2S) - scintillation ceramics | 2019 | Nuctech Co Ltd | 0 |
| Process for the preparation of gadolinium oxysulfide (Gd2O2S) scintillation ceramics | 2017 | Nuctech Co Ltd | 0 |
Where research is gaining momentum
Research themes ranked by publication activity show where scientific interest is accelerating around this compound.
| # | Research topic | Papers |
|---|---|---|
| 1 | Atomic and Subatomic Physics Research | 1 |
| 2 | thermodynamics and calorimetric analyses | 1 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | I. Kandarakis | Technological Educational Institute of Athens | 6 |
| 2 | D. Cavouras | Technological Educational Institute of Athens | 5 |
| 3 | George Panayiotakis | University of Patras | 4 |
| 4 | Marine Vincent | Université Fédérale de Toulouse Midi-Pyrénées | 2 |
| 5 | Jeffrey N. Anker | Clemson University | 3 |
| 6 | Marc Verelst | Université Fédérale de Toulouse Midi-Pyrénées | 3 |
| 7 | P. Liaparinos | University of Patras | 3 |
| 8 | Robert Mauricot | Université Fédérale de Toulouse Midi-Pyrénées | 3 |
| 9 | Séverine Lechevallier | Université Fédérale de Toulouse Midi-Pyrénées | 3 |
| 10 | Alex Lempicki | 2 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Tomographic molecular imaging of x-ray-excitable nanoparticles | 2010 | 134 | Advanced MRI Techniques and Applications |
| Flat detectors and their clinical applications | 2005 | 134 | Medical Imaging Techniques and Applications |
| Monitoring pH-Triggered Drug Release from Radioluminescent Nanocapsules with X-ray Excited Optical Luminescence | 2013 | 126 | Nanoparticle-Based Drug Delivery |
| Evaluating x-ray detectors for radiographic applications: A comparison of ZnSCdS:Ag with and screens | 1997 | 90 | Digital Radiography and Breast Imaging |
| Modeling granular phosphor screens by Monte Carlo methods | 2006 | 83 | Luminescence Properties of Advanced Materials |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular composition of gadolinium oxysulfide?
Which companies hold the most patents related to gadolinium oxysulfide?
What are the primary patent technology classifications for gadolinium oxysulfide inventions?
What recent research has examined gadolinium oxysulfide in medical imaging applications?
How has patent activity for gadolinium oxysulfide changed in recent years?